Last reviewed · How we verify

NCT07098221: H2REST

Hydrogen-Rich Water and Resting Metabolism in Young Adults

Not yet recruiting NA Last updated 1 August 2025
What this trial tests

NA trial testing Molecular Hydrogen in Healthy Subjects or Volunteers in 24 participants. Not yet recruiting.

Timeline
1 September 2025
Primary endpoint
1 December 2025
1 December 2025

Quick facts

Lead sponsorUniversity of Novi Sad
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingtriple
Primary purposebasic science
Enrollment24
Start date1 September 2025
Primary completion1 December 2025
Estimated completion1 December 2025

Drugs / interventions tested

Conditions studied

Sponsor

University of Novi Sad

Who can join

18 and older, any sex, with Healthy Subjects or Volunteers. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The H2REST trial is a randomized, double-blind, placebo-controlled crossover study investigating the acute effects of a single dose of hydrogen-rich water (HRW) on resting metabolism in healthy young adults. Participants complete two testing sessions-receiving either HRW or placebo in a randomized order-followed by standardized metabolic testing. Primary outcomes include resting energy expenditure, respiratory exchange ratio, and substrate utilization measured via indirect calorimetry. The study aims to assess whether acute HRW intake can modulate metabolic rate and fuel preference at rest, and to explore inter-individual variability in response.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other University of Novi Sad trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07098221.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing